A detailed history of Fiducient Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fiducient Advisors LLC holds 313 shares of LLY stock, worth $236,315. This represents 0.03% of its overall portfolio holdings.

Number of Shares
313
Previous 783 60.03%
Holding current value
$236,315
Previous $708,000 60.88%
% of portfolio
0.03%
Previous 0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$772.14 - $960.02 $362,905 - $451,209
-470 Reduced 60.03%
313 $277,000
Q2 2024

Aug 06, 2024

BUY
$724.87 - $909.04 $32,619 - $40,906
45 Added 6.1%
783 $708,000
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $387,590 - $456,917
738 New
738 $430,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fiducient Advisors LLC Portfolio

Follow Fiducient Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiducient Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiducient Advisors LLC with notifications on news.